Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke

JAMA Intern Med. 2022 May 1;182(5):559-564. doi: 10.1001/jamainternmed.2022.0323.

Abstract

This cohort study examines patterns in prescriptions of dual antiplatelet therapy after publication of important trials and release of updated guidelines.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aspirin / therapeutic use
  • Clopidogrel / therapeutic use
  • Drug Therapy, Combination
  • Humans
  • Ischemic Attack, Transient* / drug therapy
  • Ischemic Attack, Transient* / prevention & control
  • Ischemic Stroke*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Secondary Prevention
  • Stroke* / prevention & control

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Aspirin